Myrtenal inhibits acetylcholinesterase, a known Alzheimer target

J Pharm Pharmacol. 2011 Oct;63(10):1368-71. doi: 10.1111/j.2042-7158.2011.01344.x. Epub 2011 Aug 19.

Abstract

Objectives: Inhibition of acetylcholinesterase (AChE) is a common treatment for early stages of the most general form of dementia, Alzheimer's disease. In this study selected components of essential oils, which carry a variety of important functional groups, were tested for their in-vitro anti-acetylcholinesterase activity.

Methods: In-vitro anti-acetylcholinesterase activity was measured by an adapted version of Ellman's colorimetric assay.

Key findings: 1,8-cineole, carvacrol, myrtenal and verbenone apparently inhibited AChE; the highest inhibitory activity was observed for myrtenal (IC50 = 0.17 mm). This is the first study showing the AChE inhibitory activity of myrtenal.

Conclusions: Our investigations provided evidence for the efficacy of monoterpenes as inhibitors of AChE.

MeSH terms

  • Acetylcholinesterase / metabolism*
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Bicyclic Monoterpenes
  • Cholinesterase Inhibitors / pharmacology*
  • Cholinesterase Inhibitors / therapeutic use
  • Colorimetry
  • Cyclohexanols / pharmacology
  • Cymenes
  • Enzyme Inhibitors / pharmacology*
  • Eucalyptol
  • Humans
  • Monoterpenes / pharmacology
  • Oils, Volatile / chemistry*
  • Phytotherapy
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Terpenes / pharmacology*
  • Terpenes / therapeutic use

Substances

  • Bicyclic Monoterpenes
  • Cholinesterase Inhibitors
  • Cyclohexanols
  • Cymenes
  • Enzyme Inhibitors
  • Monoterpenes
  • Oils, Volatile
  • Plant Extracts
  • Terpenes
  • myrtenal
  • verbenone
  • carvacrol
  • Acetylcholinesterase
  • Eucalyptol